Argenx falls after ending late-stage trial for Sjögren's disease therapy
Argenx falls after ending late-stage trial for Sjögren's disease therapy
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
Argenx falls after ending late-stage trial for Sjögren's disease therapy